Perspective
Apr. 7, 2017
IP due diligence considerations in life sciences deals
Robust intellectual property protection, especially patent protection, is a critical due diligence consideration for investors. By Janet Xiao
Janet Xiao
parnter
Morrison & Foerster LLP
intellectual property
755 Page Mill Rd
Palo Alto , CA 94304
Phone: (650) 813-5736
Email: jxiao@mofo.com
UC Berkeley Boalt Hall
Janet Xiao is a partner and co-chair of the Global Life Sciences Group at Morrison & Foerster LLP. As a Chamber-ranked IP attorney, she regularly conducts IP due diligence reviews for life sciences investors.
VENTURE CAPITAL CORNER
Life sciences companies present tremendous opportunities for venture capital investors. Investing in them, however, is highly risky due to the long product development cycle and the regulatory approval uncertainties. Robust intellectual property protection, especially patent protection, is a critical consideration for investors. IP due diligence allows investors to...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In